Home › GSK in $350 million deal to develop cancer drugs with UK biotech firm - FT
 

Keywords :   


GSK in $350 million deal to develop cancer drugs with UK biotech firm - FT

2014-06-02 06:25:29| Biotech - Topix.net

GlaxoSmithKline Plc has agreed a deal worth more than $350 million with UK biotech company Adaptimmune to develop cancer drugs, the Financial Times reported on Monday.

Tags: million deal firm develop

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
24.11S
24.11
24.115
24.11SR
24.11 RC24.4.5
24.11115+128717dz
24.11lavaSUKALA 3
24.11508A
More »